Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 4:15:1339858.
doi: 10.3389/fphar.2024.1339858. eCollection 2024.

Influence of β-lactam pharmacodynamics on the systems microbiology of gram-positive and gram-negative polymicrobial communities

Affiliations

Influence of β-lactam pharmacodynamics on the systems microbiology of gram-positive and gram-negative polymicrobial communities

Nicholas M Smith et al. Front Pharmacol. .

Abstract

Objectives: We sought to evaluate the pharmacodynamics of β-lactam antibacterials against polymicrobial communities of clinically relevant gram-positive and gram-negative pathogens.

Methods: Two Enterococcus faecalis isolates, two Staphylococcus aureus isolates, and three Escherichia coli isolates with varying β-lactamase production were evaluated in static time-killing experiments. Each gram-positive isolate was exposed to a concentration array of ampicillin (E. faecalis) or cefazolin (S. aureus) alone and during co-culture with an E. coli isolate that was β-lactamase-deficient, produced TEM-1, or produced KPC-3/TEM-1B. The results of the time-killing experiments were summarized using an integrated pharmacokinetic/pharmacodynamics analysis as well as mathematical modelling to fully characterize the antibacterial pharmacodynamics.

Results: In the integrated analysis, the maximum killing of ampicillin (Emax) against both E. faecalis isolates was ≥ 4.11 during monoculture experiments or co-culture with β-lactamase-deficient E. coli, whereas the Emax was reduced to ≤ 1.54 during co-culture with β-lactamase-producing E. coli. In comparison to monoculture experiments, culturing S. aureus with KPC-producing E. coli resulted in reductions of the cefazolin Emax from 3.25 and 3.71 down to 2.02 and 2.98, respectively. Two mathematical models were created to describe the interactions between E. coli and either E. faecalis or S. aureus. When in co-culture with E. coli, S. aureus experienced a reduction in its cefazolin Kmax by 24.8% (23.1%RSE). Similarly, β-lactamase-producing E. coli preferentially protected the ampicillin-resistant E. faecalis subpopulation, reducing Kmax,r by 90.1% (14%RSE).

Discussion: β-lactamase-producing E. coli were capable of protecting S. aureus and E. faecalis from exposure to β-lactam antibacterials.

Keywords: Enterococcus faecalis; Escherichia coli; Staphylococcus aureus; beta-lactam; mechanism-based modeling; pharmacodynamic; polymicrobial; systems microbiology.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Time-killing plots depicting the activity of ampicillin against E. faecalis cultured alone or with E. coli that were either β-lactamase-deficient, produced a narrow spectrum TEM-1 enzyme, or produced TEM-1B and KPC-3. The quantity of E. faecalis is depicted for both monoculture (solid lines) and co-culture (dashed line) experiments.
FIGURE 2
FIGURE 2
Time-killing plots depicting the activity of cefazolin against S. aureus cultured alone or with E. coli that were either β-lactamase-deficient, produced a narrow spectrum TEM-1 enzyme, or produced TEM-1B and KPC-3. The quantity of S. aureus is depicted for both monoculture (solid lines) and co-culture (dashed line) experiments.
FIGURE 3
FIGURE 3
Results of an integrated PK/PD analysis are shown for both E. faecalis (top) and S. aureus (bottom) isolates investigated in the study. The Log Ratio Areas obtained from time-killing experiments were described by a mathematical Hill-type model in which Emax represents maximum antibacterial activity. The Log Ratio Areas of E. faecalis and S. aureus are shown for monoculture experiments (black circles) and co-culture with β-lactamase deficient E. coli (red triangles), E. coli producing TEM-1 (green squares), and E. coli producing KPC-3 and TEM-1B enzymes (blue diamonds). A Hill-type model was not able to describe some of the data for E. faecalis AR Bank #0671 due to lack of bacterial killing.
FIGURE 4
FIGURE 4
Model Diagrams. Two models were developed to describe each co-culture condition (S. aureus-E. coli and E. faecalis-E. coli). Experimental results of S. aureus in co-culture with E. coli were best described by using a subpopulation-based model where S. aureus was described by three sub-populations, principally differentiated by the sensitivity to either ampicillin or cefazolin. E. faecalis data were best characterized by two subpopulations with different rates of killing by ampicillin. For both models, E. coli total counts were best characterized by a two-subpopulation structure.
FIGURE 5
FIGURE 5
Observations versus individual predictions.
FIGURE 6
FIGURE 6
Observations versus individual predictions.
FIGURE 7
FIGURE 7
Our overall methodology involved detailed study of two different gram-positive bacteria, S. aureus and E. faecalis, alone and in co-culture with three different E. coli expressing different beta-lactamases. All experiments were performed using all possible combinations of S. aureus and E. coli strains along with all possible combinations of E. faecalis and E. coli strains, unless otherwise noted. Drug exposure were based on the typical first-line agent for each gram-positive. (i.e., primarily focused on use of cefazolin against S. aureus and ampicillin against E. faecalis). Please note that graphs of different bacterial killing effects are representative, only. aCefazolin susceptible. bAmpicillin susceptible. cNon-beta-lactamase producer. dTEM-1-producing. eKPC-3- and TEM-1B-co-producing (Created with BioRender.com).

Similar articles

References

    1. Centers for Disease Control (2023). Biggest threats and data. Available at: https://www.cdc.gov/drugresistance/biggest-threats.html (Accessed on July 26, 2023).
    1. WHO (2017). WHO Publishes list of bacteria for which new antibiotics are urgently needed. WHO. Media Centre. News Release. Available at: https://www.who.int/en/news-room/detail/27-02-2017-who-publishes-list-of... (Accessed July 25, 2023).
    1. Athamanolap P., Hsieh K., Wang A. T. (2018). Integrated bacterial identification and antimicrobial susceptibility testing for polymicrobial infections using digital PCR and digital high-resolution melt in a microfluidic array platform. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. 2018, 5346–5349. 10.1109/EMBC.2018.8513472 - DOI - PubMed
    1. Beaudoin T., Yau Y. C. W., Stapleton P. J., Gong Y., Wang P. W., Guttman D. S., et al. (2017). Staphylococcus aureus interaction with Pseudomonas aeruginosa biofilm enhances tobramycin resistance. NPJ Biofilms Microbiomes 3, 25. 10.1038/s41522-017-0035-0 - DOI - PMC - PubMed
    1. Briaud P., Camus L., Bastien S., Doléans-Jordheim A., Vandenesch F., Moreau K. (2019). Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells. Sci. Rep. 9, 16564. 10.1038/s41598-019-52975-z - DOI - PMC - PubMed

LinkOut - more resources